Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Agile Therapeutics (AGRX) has shared an update.
Agile Therapeutics recently completed a significant merger, resulting in substantial changes to the company’s stock structure. As a consequence, all shares of Agile’s common stock were converted into a cash entitlement for shareholders, stock plans were terminated, and no new equity awards will be issued. This merger also ushered in a new board of directors and executive officers, signaling a fresh chapter for the company. Additionally, Agile’s stock will cease public trading and quoting on the OTCQB Market, marking the end of its presence as a publicly-traded entity.
Learn more about AGRX stock on TipRanks’ Stock Analysis page.